Clinical Trial Update: Prevalence of the Mutational Status of V-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) in Metastatic Colorectal Cancer (mCRC) in Argentine Patients

View source ↗

Summary

A completed clinical trial evaluating how common KRAS mutations are in Argentine patients with metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Colorectal Neoplasms | Status: COMPLETED